Last, the expression of caveolin 1 (CAV1), a marker of lipid regulation and mitochondrial signaling which is known to have a protective role against hepatic steatosis and hepatocyte injury in NAFLD [26] was tested. Here, CAV1 is linked to metabolic dysfunction-associated steatotic liver disease.